Oridonin enhances antitumor effects of doxorubicin in human osteosarcoma cells

ROS Generation and Antioxidant Defense Systems in Normal and Malignant Cells

(2019) Anastasiya V. Snezhkina et al.   Oxidative Medicine and Cellular Longevity

Oridonin synergistically enhances the anti-tumor efficacy of doxorubicin against aggressive breast cancer via pro-apoptotic and anti-angiogenic effects

(2019) Jingjing Li et al.   PHARMACOLOGICAL RESEARCH

Oridonin exerts anticancer effect on osteosarcoma by activating PPAR-γ and inhibiting Nrf2 pathway

(2018) Ying Lu et al.   Cell Death & Disease

Oridonin synergizes with Nutlin-3 in osteosarcoma cells by modulating the levels of multiple Bcl-2 family proteins

(2017) Xiao-Hui Wang et al.   TUMOR BIOLOGY

Escin induces caspase-dependent apoptosis and autophagy through the ROS/p38 MAPK signalling pathway in human osteosarcoma cells in vitro and in vivo

(2017) Jian Zhu et al.   Cell Death & Disease

Oridonin induces autophagy via inhibition of glucose metabolism in p53-mutated colorectal cancer cells

(2017) Zhuo Yao et al.   Cell Death & Disease

Oridonin inhibits breast cancer growth and metastasis through blocking the Notch signaling

(2017) Shixin Xia et al.   SAUDI PHARMACEUTICAL JOURNAL

Oridonin induces apoptosis and reverses drug resistance in cisplatin resistant human gastric cancer cells

(2017) Zhongwei He et al.   Oncology Letters

Mcl-1 regulates reactive oxygen species via NOX4 during chemotherapy-induced senescence

(2017) Abeba Demelash et al.   Oncotarget

Inhibition of nuclear factor κB transcription activity drives a synergistic effect of cisplatin and oridonin on HepG2 human hepatocellular carcinoma cells

(2016) Xinjun Dong et al.   ANTI-CANCER DRUGS

Update on Survival in Osteosarcoma

(2016) Megan E. Anderson   ORTHOPEDIC CLINICS OF NORTH AMERICA

Combination treatment with doxorubicin and gamitrinib synergistically augments anticancer activity through enhanced activation of Bim

(2014) Hye-Kyung Park et al.   BMC CANCER

The Efficacy of Abraxane on Osteosarcoma Xenografts in Nude Mice and Expression of Secreted Protein, Acidic and Rich in Cysteine

(2012) Yongkun Yang et al.   AMERICAN JOURNAL OF THE MEDICAL SCIENCES

Anti-cancer natural products isolated from chinese medicinal herbs

(2011) Wen Tan et al.   Chinese Medicine

Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method

(2010) T.-C. Chou   CANCER RESEARCH

Sequelae of osteosarcoma medical therapy: a review of rare acute toxicities and late effects

(2010) Katherine A Janeway et al.   LANCET ONCOLOGY

Doxorubicin pathways

(2010) Caroline F. Thorn et al.   Pharmacogenetics and Genomics

Mechanisms of drug combinations: interaction and network perspectives

(2009) Jia Jia et al.   NATURE REVIEWS DRUG DISCOVERY